
Page#1
Table 1:  Kometabio Income Statement ( Projections) 
 
Year 2012 2013 2014 2015 2016 2017 2018 
 
 
Sales Revenues 0  44,000  239,300  1,066,667  4,420,000  10,400,000  14,616,667 
COGS % 0% 14% 13% 16% 19% 20% 20% 
Cost of Sales 0  6,250  30,750  168,500  841,000  2,111,000  2,958,500 
Gross Profit 0 37,750 208,550 898,167 3,579,000 8,289,000 11,658,167 
Marketing Expenses 6,000  42,000  93,000  404,000  795,000  795,000  795,000 
Gen. & Admin. expenses 20,000  104,000  93,000  422,000  790,000  790,000  790,000 
Operating Income (26,000) (108,250) 22,550 72,167 1,994,000 6,704,000 10,073,167 
Interest Expense 0  0  0  1,429  1,429  1,429  1,429 
Ops. Dev. And Shipping 110,000  50,000  45,000  45,000  45,000  45,000  45,000 
Interest Income 0  0  0  0  10,768  29,109  101,999 
Profit Before Taxes (136,000) (158,250) (22,450) 25,738  1,958,339  6,686,681  10,128,737 
Corporate Tax  0  0  0  9,266  705,002  2,407,205  3,646,345 
Net Profit (136,000) (158,250) (22,450) 16,472  1,253,337  4,279,476  6,482,392 
Cash Dividends 0  0  0  0  0  0  0 
Last Yr. Retained Earnings 0  (136,000) (294,250) (316,700) (300,228) 953,109  5,232,585 
Retained Earnings (136,000) (294,250) (316,700) (300,228) 953,109  5,232,585  11,714,977 